Literature DB >> 15155235

Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo.

Jagath L Kadurugamuwa1, Lin V Sin, Jun Yu, Kevin P Francis, Tony F Purchio, Pamela R Contag.   

Abstract

Eradication of Staphylococcus aureus biofilms after rifampin treatment was tested in a mouse model of device-related infection by using biophotonic imaging. Following treatment, the bioluminescent signals decreased to undetectable levels, irrespective of the age of the biofilm. After the final treatment, the signals rebounded in a time-dependent manner and reached those for the untreated mice. Readministration of rifampin was unsuccessful in eradicating reestablished infections, with the rifampin MICs for such bacteria being increased and with the bacteria having point mutations in the rpoB gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155235      PMCID: PMC415634          DOI: 10.1128/AAC.48.6.2283-2287.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.

Authors:  H L Rocchetta; C J Boylan; J W Foley; P W Iversen; D L LeTourneau; C L McMillian; P R Contag; D E Jenkins; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 2.  Novel approaches to monitor bacterial gene expression in infected tissue and host.

Authors:  S H Lee; A Camilli
Journal:  Curr Opin Microbiol       Date:  2000-02       Impact factor: 7.934

3.  Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging.

Authors:  Michael R Hamblin; David A O'Donnell; Naveen Murthy; Christopher H Contag; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2002-01       Impact factor: 3.421

4.  Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter.

Authors:  G R Siragusa; K Nawotka; S D Spilman; P R Contag; C H Contag
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

5.  Treatment of chronic infections with rifamycins: is resistance likely to follow?

Authors:  Richard E Chaisson
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

6.  mecA gene is widely disseminated in Staphylococcus aureus population.

Authors:  C L C Wielders; A C Fluit; S Brisse; J Verhoef; F J Schmitz
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon.

Authors:  K P Francis; J Yu; C Bellinger-Kawahara; D Joh; M J Hawkinson; G Xiao; T F Purchio; M G Caparon; M Lipsitch; P R Contag
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models.

Authors:  Nelly A Kuklin; Gregory D Pancari; Timothy W Tobery; Leslie Cope; Jesse Jackson; Charles Gill; Karen Overbye; Kevin P Francis; Jun Yu; Donna Montgomery; Annaliesa S Anderson; William McClements; Kathrin U Jansen
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.

Authors:  Marshall C Walters; Frank Roe; Amandine Bugnicourt; Michael J Franklin; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Direct continuous method for monitoring biofilm infection in a mouse model.

Authors:  Jagath L Kadurugamuwa; Lin Sin; Eddie Albert; Jun Yu; Kevin Francis; Monica DeBoer; Michael Rubin; Carole Bellinger-Kawahara; T R Parr; Pamela R Contag
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more
  21 in total

1.  Optical Imaging of Bacterial Infection Models.

Authors:  W Matthew Leevy; Nathan Serazin; Bradley D Smith
Journal:  Drug Discov Today Dis Models       Date:  2007

Review 2.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

3.  In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model.

Authors:  Victoria Garrido; María Collantes; Montserrat Barberán; Iván Peñuelas; Javier Arbizu; Beatriz Amorena; María-Jesús Grilló
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

4.  Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model.

Authors:  Yan Q Xiong; Julie Willard; Jagath L Kadurugamuwa; Jun Yu; Kevin P Francis; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Jun Yu; Kevin P Francis; Tony Purchio; Pamela R Contag
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis.

Authors:  Yefei Zhu; Elizabeth C Weiss; Michael Otto; Paul D Fey; Mark S Smeltzer; Greg A Somerville
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

7.  Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up.

Authors:  Baochao Ji; Boyong Xu; Wentao Guo; Aili Rehei; Wenbo Mu; Desheng Yang; Li Cao
Journal:  Int Orthop       Date:  2016-09-20       Impact factor: 3.075

8.  In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.

Authors:  Christopher K Murphy; Steve Mullin; Marcia S Osburne; John van Duzer; Jim Siedlecki; Xiang Yu; Kathy Kerstein; Michael Cynamon; David M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.

Authors:  Gregory T Robertson; Eric J Bonventre; Timothy B Doyle; Qun Du; Leonard Duncan; Timothy W Morris; Eric D Roche; Dalai Yan; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 10.  Two-stage procedure in the treatment of late chronic hip infections--spacer implantation.

Authors:  Mohamed Sukeik; Fares S Haddad
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.